Topic

C

Corporate Communications

D

Direct-to-Consumer

E

Emerging Biopharma

I

IR Licensing and Partnerships

M

O

Operations

P

Patient Engagement

R

Regulatory

S

Sales & Marketing

Trending on PharmExec

FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes

Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report

M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel

Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals

Preventing Batch Loss: The Growing Role of Preventive and Predictive Maintenance